Publication | Closed Access

Targeted immunomodulation of inflammatory monocytes across the blood-brain barrier by curcumin-loaded nanoparticles delays the progression of experimental autoimmune encephalomyelitis

InflammationNanomedicineNanotherapeuticsEngineeringMedicineImmunoengineeringPharmacologyImmunologyInflammatory MonocytesBlood-brain BarrierBrain-immune InteractionNano-drug DeliveryCurcumin-loaded NanoparticlesImmunotherapyNeuroimmunologyNeuroinflammation